Xeris Biopharma (XERS) Revenue (2020 - 2026)
Xeris Biopharma (XERS) revenue from Mar 31, 2020 to Mar 31, 2026. The TTM Xeris Biopharma (XERS) revenue is $315M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Revenue
Quarterly Revenue
Xeris Biopharma (XERS) Revenue CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +41.47% |
| 3 Years TTM | +37.40% |
| 5 Years TTM | +62.02% |
| All Time TTM | +62.03% |
Annual Revenue change of Xeris Biopharma (XERS)
| Year | Revenue | Change |
|---|---|---|
| 2026 | $83M | -71.52% |
| 2025 | $292M | +43.72% |
| 2024 | $203M | +23.89% |
| 2023 | $164M | +48.67% |
| 2022 | $110M | +122.32% |
| 2021 | $50M | +145.98% |
| 2020 | $20M | N/A |
Comparison Xeris Biopharma (XERS) five years revenue CAGR with competitors
Xeris Biopharma (XERS) five years revenue CAGR is 62.01%.